Dermatology · San Diego area, CA
Dermatology and skin studies in San Diego area, CA
22 recruiting studies have a site in the San Diego area. This page includes nearby cities such as La Jolla, Chula Vista, Escondido, Oceanside.
22 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Pfizer
- Location
- Anaheim, CA + 4 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
A Study to Assess Deucravacitinib Safety in Pregnancy
Bristol-Myers Squibb
- Location
- La Jolla, CA
- Eligibility basics
- Any age listed · Women only
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Fountain Valley, CA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Sanofi
- Location
- La Jolla, CA + 17 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Pfizer
- Location
- Northridge, CA + 7 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Fountain Valley, CA + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Encinitas, CA + 90 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Novartis Pharmaceuticals
- Location
- Fountain Valley, CA + 23 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Takeda
- Location
- Fountain Valley, CA + 20 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Pfizer
- Location
- San Diego, CA + 12 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Beverly Hills, CA + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Janssen Research & Development, LLC
- Location
- Huntington Beach, CA + 17 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Inglewood, CA + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Takeda
- Location
- Chula Vista, CA + 10 other US sites
- Eligibility basics
- Ages 4–17
- RecruitingPhase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Takeda
- Location
- Fountain Valley, CA + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Los Angeles, CA + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Cerritos, CA + 78 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Encinitas, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
InventisBio Co., Ltd
- Location
- Chula Vista, CA + 2 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Palo Alto, CA + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Bakersfield, CA + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
AbbVie
- Location
- Redondo Beach, CA + 9 other US sites
- Eligibility basics
- Ages 22+
Who these studies look for
Most require an active, diagnosed skin condition of a certain severity and a pause on some current treatments before starting.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.